$9.32
0.53%
Nasdaq, Jul 03, 07:23 pm CET
ISIN
US00653Q1022
Symbol
AHCO

AdaptHealth Corp - Ordinary Shares - Class A Stock price

$9.32
+0.46 5.19% 1M
-0.32 3.32% 6M
-0.20 2.10% YTD
-0.38 3.92% 1Y
-8.85 48.71% 3Y
-10.68 53.40% 5Y
-0.38 3.92% 10Y
-0.38 3.92% 20Y
Nasdaq, Closing price Thu, Jul 03 2025
-0.05 0.53%
ISIN
US00653Q1022
Symbol
AHCO
Sector

Key metrics

Basic
Market capitalization
$1.3b
Enterprise Value
-
Net debt
-
Cash
-
Shares outstanding
-
Valuation (TTM | estimate)
P/E
16.6 | 11.2
P/S
0.3 | 0.4
EV/Sales
- | -
EV/FCF
-
P/B
-
Financial Health
Equity Ratio
35.0%
Return on Equity
5.3%
ROCE
-
ROIC
-
Debt/Equity
-
Financials (TTM | estimate)
Revenue
$4.0b | $3.3b
EBITDA
$386.9m | $693.6m
EBIT
$331.5m | $293.8m
Net Income
$76.7m | -
Free Cash Flow
$274.6m
Growth (TTM | estimate)
Revenue
24.4% | 1.7%
EBITDA
20.8% | 97.9%
EBIT
23.9%
Net Income
111.0% | -
Free Cash Flow
415.6%
Margin (TTM | estimate)
Gross
22.1%
EBITDA
9.6% | 20.9%
EBIT
8.2%
Net
1.9% | -
Free Cash Flow
6.8%
More
EPS
$0.6
FCF per Share
-
Short interest
8.4%
Employees
11k
Rev per Employee
$310.0k
Show more

Is AdaptHealth Corp - Ordinary Shares - Class A a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,966 stocks worldwide.

AdaptHealth Corp - Ordinary Shares - Class A Stock Analysis

Unlock Scores for Free

Analyst Opinions

14 Analysts have issued a AdaptHealth Corp - Ordinary Shares - Class A forecast:

11x Buy
79%
3x Hold
21%

Analyst Opinions

14 Analysts have issued a AdaptHealth Corp - Ordinary Shares - Class A forecast:

Buy
79%
Hold
21%

Financial data from AdaptHealth Corp - Ordinary Shares - Class A

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
4,039 4,039
24% 24%
100%
- Direct Costs 3,145 3,145
19% 19%
78%
894 894
49% 49%
22%
- Selling and Administrative Expenses 507 507
82% 82%
13%
- Research and Development Expense - -
-
-
387 387
21% 21%
10%
- Depreciation and Amortization 55 55
5% 5%
1%
EBIT (Operating Income) EBIT 331 331
24% 24%
8%
Net Profit 77 77
111% 111%
2%

In millions USD.

Don't miss a Thing! We will send you all news about AdaptHealth Corp - Ordinary Shares - Class A directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

AdaptHealth Corp - Ordinary Shares - Class A Stock News

Neutral
Business Wire
6 days ago
CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--AdaptHealth Corp. (NASDAQ: AHCO) (“AdaptHealth” or the “Company”), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, today announced that it has closed on the previously disclosed disposition of certain infusion assets in its Wellness at Home segment to a thi...
Negative
Seeking Alpha
about one month ago
AdaptHealth's national scale and AI-driven efficiencies position it well for value-based contracts, aiming to curb hospital readmissions and improve EBITDA margins. The company faces potential risks from competitive-bidding discounts, unresolved litigation, and execution challenges on the One Adapt ERP migration. Management's 2025 guidance suggests flat organic revenue and a 21% EBITDA margin, ...
Neutral
Business Wire
about 2 months ago
PLYMOUTH MEETING, Pa.--(BUSINESS WIRE)--AdaptHealth Corp. (NASDAQ: AHCO) (“AdaptHealth” or the “Company”), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, announced today that they will participate in the following upcoming investor conferences: The Barclays Leveraged Finance Conference, bein...
More AdaptHealth Corp - Ordinary Shares - Class A News

Company Profile

AdaptHealth Corp. engages in the provision of home healthcare equipment, supplies and related services. It focuses providing sleep therapy equipment to individuals suffering from obstructive sleep apnea (OSA), home medical equipment to patients discharged from acute care and other facilities, oxygen and related chronic therapy services in the home, and HME medical devices and supplies on behalf of chronically ill patients with diabetes care, wound care, urological, ostomy and nutritional supply needs. The company was founded in 2012 and is headquartered in Plymouth Meeting, PA.

Head office United States
CEO Suzanne Foster
Employees 10,500
Founded 2012
Website adapthealth.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today